Effects of Chronic Administration of Zonisamide, an Antiepileptic Drug, on Bone Mineral Density and Their Prevention With Alfacalcidol in Growing Rats
We investigated the effects of chronic administration of zonisamide, an antiepileptic agent, on bone metabolism in growing rats. Administration of zonisamide at a dose of 80 mg/kg per day, s.c. for 5 weeks significantly decreased bone mineral density (BMD) at the tibial metaphysis and the diaphysis....
Saved in:
Main Authors: | Atsushi Takahashi (Author), Kenji Onodera (Author), Junzo Kamei (Author), Shinobu Sakurada (Author), Hisashi Shinoda (Author), Shuichi Miyazaki (Author), Takashi Saito (Author), Hideaki Mayanagi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2003-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-drug interactions in the new antiepileptic drugs: focus to perampanel and zonisamide
by: Y. B. Belousov
Published: (2014) -
Bone Mineral Density Unaffected by Antiepileptics
by: J Gordon Millichap
Published: (1998) -
Peroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
by: Yuanying Li, et al.
Published: (2022) -
Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
by: Mohammed Emamussalehin Choudhury, et al.
Published: (2010) -
Probable drug-induced lupus erythematosus by zonisamide
by: Mohannad G. Safadi, BS, et al.
Published: (2021)